Clinical Results From CollPlant's Advanced Wound Care Product VergenixFG to Be Presented at European Wound Management Association Conference
CollPlant Biotechnologies Ltd. - Ordinary Shares (CLGN)
US:NASDAQ Investor Relations:
collplant.com/investor-relation
Company Research
Source: PR Newswire
REHOVOT, Israel, June 4, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced that the results from a clinical study conducted with its VergenixFG advanced wound care product will be presented at the 29th Conference of the European Wound Management Association (EWMA). The EWMA conference will take place from June 5-7, 2019 in Gothenburg, Sweden. It is one of the largest wound conferences in the world, gathering the European and international wound management communities with the common goal of improving patient wound care. On Friday June 7, 2019, from 10.30 AM - 11.30 AM, Dr. Eyal Shapira from the department of Plastic Surgery, Assaf Harofeh Medical Center, Israel, will present clinical results published in Wounds, a peer reviewed journal focused on wound care and wound research. The abstract titled, "A novel recombinant human collagen-based flowable matrix for chronic lower limb wound management: first results of a clinical trial" presents
Show less
Read more
Impact Snapshot
Event Time:
CLGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLGN alerts
High impacting CollPlant Biotechnologies Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
CLGN
News
- CollPlant Biotechnologies Ltd. (NASDAQ: CLGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.MarketBeat
- CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Highlights: Navigating Revenue ... [Yahoo! Finance]Yahoo! Finance
- CollPlant Biotechnologies Ltd. (NASDAQ: CLGN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.MarketBeat
- COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE [Yahoo! Finance]Yahoo! Finance
- COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATEPR Newswire
CLGN
Earnings
- 11/27/24 - Beat
CLGN
Analyst Actions
- 11/29/24 - HC Wainwright
CLGN
Sec Filings
- 11/27/24 - Form 6-K
- 9/25/24 - Form 6-K
- CLGN's page on the SEC website